¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Mixed bacterial vaccines, except combinations with a pertussis component"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bacterial antagonism
    ¼¼±Õ´ëÇ×ÀÛ¿ë, ¼¼±Õ¸Â¹öÆÀÀÛ¿ë
  • bacterial artificial chromosome
    ¹ÚÅ׸®¾Æ¼ºÀΰø¿°»öü
  • bacterial colony
    ¼¼±ÕÁý¶ô
  • bacterial conjugation
    ¼¼±ÕÁ¢ÇÕ
  • bacterial cytology
    ¼¼±Õ¼¼Æ÷ÇÐ
  • bacterial decomposition
    ¼¼±ÕºÐÇØ
  • bacterial endocarditis
    ¼¼±Õ½É³»¸·¿°
  • bacterial flora
    ¼¼±Õ¹«¸®
  • bacterial growth rate
    ¼¼±ÕÁõ½Ä·ü
  • bacterial strain
    ¼¼±ÕÁÖ
  • bacterial translocation
    ¼¼±ÕÀüÀ§
  • bacterial vaginosis
    ¼¼±ÕÁúÁõ
  • subacute bacterial endocarditis
    ¾Æ±Þ¼º¼¼±Õ½É³»¸·¿°
  • mixed acid
    È¥ÇÕ»ê
  • mixed aphasia
    È¥ÇÕ¾ð¾î»ó½ÇÁõ, È¥ÇսǾîÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bacterial antagonism
    ¼¼±Õ¸Â¹öÆÀÀÛ¿ë
  • bacterial
    ¼¼±Õ-
  • bacterial colony
    ¼¼±ÕÁý¶ô
  • bacterial conjugation
    ¼¼±ÕÁ¢ÇÕ
  • bacterial cytology
    ¼¼±Õ¼¼Æ÷ÇÐ
  • bacterial decomposition
    ¼¼±ÕºÐÇØ
  • bacterial disease
    ¼¼±Õº´
  • bacterial exotoxin
    ¼¼±Õ¿Üµ¶¼Ò
  • bacterial flora
    ¼¼±Õ¹«¸®
  • bacterial shock
    ¼¼±Õ¼îÅ©
  • bacterial species
    ¼¼±ÕÁ¾
  • bacterial strain
    ±ÕÁÖ
  • bacterial growth rate
    ¼¼±ÕÁõ½Ä·ü
  • bacterial interference therapy
    ¼¼±Õ°£¼·¿ä¹ý
  • total bacterial count
    Ãѱռö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Bordetella pertussis
    º¸¸£µ¥ÅÚ¶ó ¹éÀÏÇØ.
  • Diphtheria Tetanus Pertussis =DTP
    µðÇÁÅ׸®¾Æ Åן´©½º ¹éÀÏÇØ ¿¹¹æÁÖ »ç¾×.
  • SBE= subacute bacterial endocarditis
    ¾Æ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°.
  • acute bacterial arthritis
    ±Þ¼º ¼¼±Õ¼º °üÀý¿°(Ðáàõá¬Ð¶àõÎ¼ï½æú).
  • acute bacterial arthritis
    ±Þ¼º ¼¼±Õ¼º °üÀý¿°(¡­á¬Ð¶àõÎ¼ï½æú).
  • acute bacterial endocarditis
    ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°(¡­á¬Ð¶àõãýҮدæú).
  • adjuvant, pertussis
    ¹éÀÏÇØ±Õ ¾ÆÁÖ¹ÝÆ®, ¹éÀÏÇØ±Õ ¸é¿ªº¸°­Á¦
  • gelatinoid plaque =dental p., bacterial p.
    Ä¡¾Æ¼¼±Õ¸·(öÍä³á¬Ð¶Ø¯).
  • genetics, bacterial
    ¼¼±ÕÀ¯ÀüÇÐ
  • haemophilus pertussis
    Çì¸ðÇʷ罺 ÆÛÅõ½Ã½º, Haemophilus pertussis
  • pertussis
    ¹éÀÏÇØ(ÛÝìíú¦).
  • pertussis
    ¹éÀÏÇØ
  • pertussis adjuvant
    ¹éÀÏÇØ±Õ ¾ÆÁÖ¹ÝÆ®, ¹éÀÏÇØ±Õ ¸é¿ªº¸°­Á¦
  • pertussis toxin
    ¹éÀÏÇØµ¶¼Ò
  • pertussis vaccine
    ¹éÀÏÇØ¹é½Å.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • component transfusion
    ¼ººÐ¼öÇ÷.
  • component, T (transport)
    T¼ººÐ, ¼ö¼Û¼ººÐ
  • component, secretory
    ºÐºñ¼ººÐ
  • high cellular component
    °í¼¼Æ÷ ±¸¼º ¼ººÐ
  • longitudinal component
    Á¾Ãà ¿ä¼Ò
  • paramagnetic component
    »óÀÚ¼º ¼ººÐ
  • plasma component transfusion
    Ç÷À强ºÐ¼öÇ÷
  • plasma thromboplastin component =PTC
    ÇöóÁ<Ç÷Àå>Æ®·Òº¸ÇÃ¶ó½ºÆ¾¼ººÐ(¡­à÷ÝÂ
  • plasma thromboplastin component defic
    ÇöóÁ<Ç÷Àå>Æ®·Òº¸ÇÃ¶ó½ºÆ¾¼ººÐ°áÇÌ(Áõ
  • principal component
    ÁÖ¼ººÐ(ñ«à÷ÝÂ).
  • quick component
    ±Þ°Ý¼ººÐ(ÐáÌ­à÷ÝÂ).
  • secretory component
    ºÐºñ¼ººÐ
  • series elastic component
    Á÷·Äź·Â¼ººÐ(òÁ æê÷¥æ³à÷ÝÂ).
  • slow component
    ¿Ï¼­¼ººÐ(èÐßïà÷ÝÂ).
  • third component
    Á¦»ï¼ººÐ(ð¯ß²à÷ÝÂ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mixed inhibition
    È¥ÇÕÀúÇØ(ûèùêîÁúª)
  • mixed lactic fermentation
    È¥ÇÕÀ¯»ê¹ßÈ¿(ûèùêêáۣ߫ý£)
  • mixed lymphocyte culture
    È¥ÇÕ(ûèùê)¸²ÆÄ±¸¹è¾ç(ÛÆå×)
  • mixed micelle
    È¥¼º(ûèà÷)¹Ì¼¿
  • mixed-order reaction
    È¥ÇÕ¼øÂ÷ ¹ÝÀÀ(ûèùêâ÷ó­Úãëë)
  • mixed surface film
    È¥ÇÕÇ¥¸é(ûèùêøúØü)Çʸ§
  • mixed triglyceride
    È¥¼º(ûèà÷)Æ®¸®±Û¸®¼¼¶óÀ̵å
  • mixed-type inhibitor
    È¥ÇÕÇü ÀúÇØÁ¦(ûèùêúþîÁúªð¥)
  • mixed vaccine
    È¥¼º(ûèà÷)¹é½Å
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MC mass casualties; mast cell; Master of Surgery [Lat. Magister Chirurgiae]; maximum concentration; Med...
MLTC mixed leukocyte-trophoblast culture; mixed lymphocyte tumor cell
DPT Diphtheria-Pertussis-Tetanus; µðÇÁÅ׸®¾Æ, ¹éÀÏÇØ, ÆÄ»ódz
DTP Diphtheria, Tetanus, Pertussis µðÇÁÅ׸®¾Æ, ÆÄ»ódz, ¹éÀÏÇØ È¥ÇÕ ¹é½Å
DPI daily permissible intake; days post inoculation; dietary protein intake; diphtheria-pertussis immuni...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DTP Diphtheria-tetanus-pertussis vaccine
PT Pertussis Toxin
PTX Pertussis Toxin
PV Pertussis vaccine
DTP diphtheria tetanus pertussis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute bacterial meningitis
    ±Þ¼º ¼¼±Õ¼º ³ú¸·¿°
  • acute bacterial sialadenitis
    ±Þ¼º ¼¼±Õ¼º Ÿ¾×¼±¿°
  • bacterial
    ¼¼±Õ¼º, ¼¼±ÕÀÇ, ¼¼±Õ¼ºÀÇ
    ¼¼±Õ¿¡ °üÇÑ ¶Ç´Â ¼¼±Õ¿¡ ±âÀÎÇÑ.
  • bacterial adherence
    ¼¼±Õ Á¢Âø¼º
  • bacterial agglutination
    ¼¼±Õ¼º ÀÀÁý ¹ÝÀÀ
    ÀÔÀÚ »ó Ç׿øÀÌ Ç×ü¿Í °áÇÕÇÏ¿© À°¾ÈÀ¸·Î È®ÀÎÇÒ ¼ö ÀÖ´Â ÀÀÁý±«¸¦ Çü¼ºÇÏ´Â ¹ÝÀÀÀ» ÀÀÁý ¹ÝÀÀÀ̶ó°í ºÎ¸£¸é ±× Áß¿¡¼­ Ç׿øÀ¸·Î¼­ ¼¼±ÕÀ» »ç¿ëÇÑ °ÍÀÌ ¼¼±Õ ÀÀÁý ¹ÝÀÀÀÌ´Ù. ÀÀÁý ¹ÝÀÀ¿¡ °ü¿©ÇÏ´Â Ç×ü¸¦ ƯÈ÷ ÀÀÁý¼Ò, Ç׿øÀ» ÀÀÁý¿øÀ̶ó°í ºÎ¸£´Â ÀÏÀÌ ÀÖ´Ù. ¼¼±ÕÀÇ ±Õü Ç¥¸é¿¡´Â ÀÀÁý¿øÀ¸·Î¼­ ÀÛ¿ëÇÒ ¼ö ÀÖ´Â ¸¹ÀÌ Ç׿øÀÌ ¾Ë·ÁÁ® Àִµ¥ °¡Àå À¯¸íÇÑ °ÍÀ¸·Î¼­ Æí¸ð Ç׿øÀÎ H Ç׿ø, ±Õü Ç׿øÀ¸·Î¼­ÀÇ O Ç׿øÀÌ ÀÖ´Ù.
  • bacterial allergy
    ¼¼±Õ¼º ÀÌ»ó ¹Î°¨Áõ
    Ư¼öÇÑ ¼¼±Õ¼º Ç׿ø. À̰ÍÀº ƯÀÌÇÑ ¹Ì»ý¹°¿¡ ÀÇÇÑ ÀÌÀüÀÇ °¨¿°À¸·Î ÀÎÇÑ °ÍÀ¸·Î, ¼øÈ¯¼ºÀÇ Ç×ü´Â º¸ÀÌÁö ¾Ê´Â´Ù.
  • bacterial baccine
    ¼¼±Õ¼º ¹é½Å
  • bacterial coagulation
    ¼¼±Õ ÀÀÁý
  • bacterial endarteritis
    ¼¼±Õ¼º µ¿¸Æ³»¸·¿°
  • bacterial endotoxin
    ¼¼±Õ³» µ¶¼Ò
    ¼¼±Õ ¼¼Æ÷ º®¿¡ Á¸ÀçÇÏÁö¸¸, Á¤»ó ¼¼±Õ ¹è¾çÀÇ ¹«¼¼Æ÷ ¿©¾×¿¡´Â Á¸ÀçÇÏÁö ¾Ê´Â ³»¿­¼º µ¶¼Ò. ¿ø·¡ ±×¶÷ À½¼º ¼¼±Õ³»¿¡ ÀÖ°í ³»µ¶¼Ò¸¦ Çü¼ºÇϰí ÀÖ´Â ´Ù´çü´Â ±Õü Ç׿ø°ú µ¿ÀÏÇÑ ¹°ÁúÀÌ´Ù.
  • bacterial flora
    ¼¼±Õ±º
  • bacterial infection
    ¼¼±Õ °¨¿°, ¼¼±Õ¼º °¨¿°, ¹ÚÅ׸®¾Æ °¨¿°
    ¼¼±Õ¿¡ ÀÇÇÑ °¨¿°. °áÇÙ±Õ°ú °°ÀÌ ¸¸¼º À°¾ÆÁ¾¼º ¿°ÁõÀ» ÀÏÀ¸Å°´Â ÀϺÎÀÇ ¼¼±ÕÀ» Á¦¿ÜÇϰí´Â ´ëºÎºÐ È­³ó¼º ¿°ÁõÀ» ÀÏÀ¸Å°¸ç µå¹°°Ô °æ¸·¿Ü ¶Ç´Â °æ¸·ÇÏ ³ó¾çÀ» Çü¼ºÇϱ⵵ ÇÏÁö¸¸ ´ë°³ È­³ó¼º ¼ö¸·¿°, ±¹¼ÒÀû ³ú¿°, ³ú ³ó¾çÀ» Çü¼ºÇÑ´Ù.
  • bacterial palque coating
    ¼¼±Õ¼º ġŠÇǸ·
    ¼¼±Õ¿¡ ÀÇÇÑ Ä¡¾ÆÇ¥¸é ¹°ÁúÀÌ Ä§ÂøÇÑ °ÍÀ¸·Î ¿ìÄ¡, Ä¡¼® Çü¼ºÀÇ ÇÙ ±×¸®°í Ä¡ÁÖº´ µîÀ» À¯¹ßÇÏ´Â ¼¼±ÕÁõ½ÄÀÇ ¹èÁö°¡ µÈ´Ù.
  • bacterial phase
    ¼¼±Õ »ó
    ¼¼±ÕÀÌ ´«¿¡ º¸ÀÌ´Â ¾ç»ó.
  • bacterial pneumonia
    ¼¼±Õ¼º Æó·Å
    ¼¼±Õ¿¡ ÀÇÇÑ °æÈ­¸¦ µ¿¹ÝÇÏ´Â ÆóÀÇ ¿°Áõ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
anterior component of force A force operating to move teeth anteriorly.
(05 Mar 2000)
blood component removal Any procedure in which blood is withdrawn from a donor, a portion is separated and retained and the remainder is returned to the donor.
(12 Dec 1998)
blood component transfusion The transfer of blood components such as erythrocytes, leukocytes, platelets, and plasma from a donor to a recipient or back to the donor. This process differs from the procedures undertaken in plasmapheresis and types of cytapheresis (plateletpheresis and leukapheresis) where, following the removal of plasma or the specific cell components, the remainder is transfused back to the donor.
(12 Dec 1998)
p18 component, aminoacyl tRNA synthetase <enzyme> Shares a protein motif with the beta and gamma subunits of eukaryotic elongation factor 1; amino acid sequence given in first source
Registry number: EC 6.1.1.-
Synonym: p18 aminoacyl-trna synthase
(26 Jun 1999)
granular component of nucleolus Area of nucleolus that appears granular in the electron microscope and contains 15nm diameter particles that are maturing ribosomes. In contrast to the pale staining and fibrillar areas.
(18 Nov 1997)
component <physiology> A constituent element or part, specifically in neurology, a series of neurons forming a functional system for conducting the afferent and efferent impulses in the somatic and splanchnic mechanisms of the body.
(05 Jan 1998)
component A, Rab geranylgeranyl transferase <chemical> Binds unprenylated rab1a and presents it to the catalytic component b; do not confuse with rep-1 from yeast; see also mrs6 protein
Synonym: rab escort protein, rab geranylgeranyltransferase component a, rep-1 protein, rab escort protein-1, choroideraemia gene product, chm gene product, mrs6 gene product
(26 Jun 1999)
component E, glutamate mutase <chemical> The large subunit of glutamate mutase; from clostridium tetanomorphum; has 485 amino acid residues; mw 53,708 da; has been sequenced
Synonym: mute gene product, clostridium, mute protein, clostridium
(26 Jun 1999)
component of complement Any one of the nine distinct protein units (designated C1 through C9 and distributed in the a, b, and g electrophoretic partitions of normal serum) that effect the immunological activities long associated with complement. C1 is a complex of three subunits: C1q, C1r, and C1s. C1q (overbar indicates "active form") activates proenzyme C1r to C1r which activates C1s to C1s (also known as C1 esterase), which converts proenzyme C2 to C2b and produces C4b from C4. C2b combines with C4b to form "classical-complement-pathway C3/C5 convertase" (also known as C3 convertase, C5 convertase, and C42). This enzyme cleaves C3 to C3a and C3b, and C5 to yield C5a and C5b, as does "alternative-complement-pathway C3/C5 convertase" (also known as proenzyme factor B, properdin factor B, C3 proactivator, and heat-labile factor). Complement factor I (also known as C3b or C3b/C4b inactivator) inactivates C3b and C4b by a different proteolytic cleavage. Several autosomal recessive disorders have been identified in which one or more of the complement components have been deficient or completely absent.
(05 Mar 2000)
component of force One of the factors from which a resultant force may be compounded or into which it may be resolved, one of the vectors into which a force may be resolved.
(05 Mar 2000)
component S, glutamate mutase <chemical> Component s of the coenzyme b12-dependent glutamate mutase from clostridium cochlearium; mw 15 kD; amino acid sequence given in first source
Synonym: glms gene product, muts gene product (clostridium)
(26 Jun 1999)
plasma thromboplastin component <chemical> Storage-stable blood coagulation factor acting in the intrinsic pathway. Its activated form, ixa, forms a complex with factor viii and calcium on platelet factor 3 to activate factor x to xa. Deficiency of factor ix results in christmas disease (haemophilia b).
Chemical name: Blood-coagulation factor IX
(12 Dec 1998)
habitat component <ecology> A single element (for example, velocity, depth, cover, etc.) of the habitat or environment in which a fish or other aquatic species or population may live or occur.
(09 Oct 1997)
secretory component <physiology> A glycoprotein found in a variety of external secretions (tears, bile, colostrum) usually complexed to secreted polymeric immunoglobulins (IgA or, less frequently IgM).
It is derived, by proteolytic cleavage, from the polymeric immunoglobulin receptor (receptors, polymeric immunoglobulin) and probably functions to protect the immunoglobulins from proteolysis in the secretions.
(12 Dec 1998)
secretory component of IgA <immunology, protein> A polypeptide chain of about 60 kD that aids secretion of the IgA, a portion of the IgA receptor on the plasmalemma of the inner side of the epithelial cells lining the gut, which is proteolysed when the IgA receptor complex has travelled through the cell after receptor mediated endocytosis at the inner face, to the outer (luminal) face.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mixed doubles
    (Å״Ͻº) ³²³à È¥ÇÕ º¹½Ä
  • mixed drink
    ÇÕ¼ºÁÖ
  • mixed economy
    (ÀÚº»ÁÖÀÇ,»çȸÁÖÀÇ º´Á¸ÀÇ)È¥ÇÕ °æÁ¦;¿µ±¹¿¡¼­ º¼ ¼ö ÀÖÀ½
  • mixed farming
    (¸ñÃàÀ» °âÇÑ)È¥ÇÕ³ó¾÷
  • mixed fertilizer
    ¹èÇÕ ºñ·á
  • mixed grill
    °£;¼Ò½ÃÁö µîÀÇ À°·ù¿Í Å丶Åä;¹ö¼¸ µîÀ» ººÀº ¿ä¸®
  • mixed market economy
    È¥ÇÕ ½ÃÀå °æÁ¦
  • mixed marriage
    (´Ù¸¥ Á¾Á·,Á¾±³°£ÀÇ) ÀâÈ¥
  • mixed media
    È¥ÇÕ ¸Åü;¿µ»ó;±×¸²;À½¾Ç µîÀÇ Á¾ÇÕÀû ¿¹¼ú Ç¥Çö
  • mixed metaphor
    È¥À¯
  • mixed number
    ´ëºÐ¼ö
  • mixed tithe
    (°¡Ãà·ù¿¡¼­ÀÇ ¼öÀÍ¿¡ ´ëÇÑ) 10ºÐÀÇ 1ÀÇ ¼¼
  • mixed train
    (°´Â÷¿Í È­Â÷ÀÇ) È¥¼º ¿­Â÷
  • ready-mixed
    ¹Ì¸® Á¶Á¦(Á¶ÇÕ,È¥ÇÕ)ÇÑ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á